Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer

NCT02257528 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

26

Enrollment

NIH

Sponsor class

Conditions

Cervical Adenocarcinoma
Cervical Adenosquamous Carcinoma
Recurrent Cervical Carcinoma
Stage IV Cervical Cancer AJCC v6 and v7
Stage IVA Cervical Cancer AJCC v6 and v7
Stage IVB Cervical Cancer AJCC v6 and v7

Interventions

OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Nivolumab

Sponsor

National Cancer Institute (NCI)

Collaborators

[object Object]